Week in Review: Nobel debate reignites | Death toll rises at imaging site | Overdiagnosis in breast screening

Dear AuntMinnieEurope Member,

Much has been said and written over the past three decades about the Nobel prize for MRI, but very little discussion has taken place about a potential award for PET imaging.

Prof. Hans Ringertz was closely involved in the judging process for many years at the Karolinska in Stockholm. He's always very careful with his words, so it's surely significant that he spoke at ECR 2022 about a Nobel prize for PET. Find out more in the Molecular Imaging Community.

Much positive energy was evident at ECR 2022, and there was a generally upbeat mood among the estimated 8,000-10,000 attendees in Vienna. However, the worsening conflict in Ukraine cast a long shadow over the congress.

On the second day of the meeting, news broke of the missile attack on an imaging facility in Vinnytsia. Neurologist Dr. Natalya Falshtynska, who was seriously injured in the attack, died in hospital on 19 July, taking the death toll to 25.

In other news, U.K. scientists have published new data on overdiagnosis in breast screening. Their findings deserve a close look in the Women's Imaging Community.

When it comes to breast MRI, does a clinical decision algorithm outweigh reader experience? A highly respected research group from Vienna has addressed this important question in a study published in European Radiology on 19 July. Go to the MRI Community to learn more.

Where access to MRI is limited or a patient has a contraindication to MRI -- for example, due to a hip prosthesis or a pacemaker -- microultrasound can help to detect lesions that are unlikely to be seen on conventional ultrasound, according to Canadian researchers.

Looking ahead, we'll bring you more news and video interviews from ECR 2022. Please watch out for them in the coming weeks.

Page 1 of 1264
Next Page